Kramer Laboratories, Inc.

FDA Regulatory Profile

Kramer Laboratories, Inc. appears in FDA public data with 2 recalls, 0 510(k) clearances, 2 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0943-2023, Class II) was initiated on June 23, 2023.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
2
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0943-2023Class IISafe Tussin PM Night Time Cough Relief (Cough Suppressant/Antihistamine), packaged in 4.0 FL OZ(118mJune 23, 2023
D-0942-2023Class IISafe Tussin DM Cough + Chest Congestion (Dextromethorphan HBr/ Cough Suppressant Guaifenesin/ExpectoJune 23, 2023